#27

Candesant’s Topical Device to Treat Excessive Sweating

With Niquette Hunt, CEO of Candesant Biomedical

Niquette Hunt, CEO, has over twenty-five years’ experience in developing, launching and commercializing 20+ products across multiple verticals in the consumer medicine market. Every business she managed increased sales, profits and/or market share. Before founding Candesant, Ms. Hunt charted the commercial strategy at Revance Therapeutics and helped raise over $250 million in the 2014 IPO and follow-on financing.

Candesant’s Topical Device to Treat Excessive Sweating

US_UK_iTunes_Store_Get_Solid_Lockup_RGB_blk_012618.jpg

 

 

Niquette Hunt, CEO, Candesant Biomedical

Hunt_NIquette-Candesant.jpg

Niquette Hunt, CEO, has over twenty-five years’ experience in developing, launching and commercializing 20+ products across multiple verticals in the consumer medicine market. Every business she managed increased sales, profits and/or market share. Before founding Candesant, Ms. Hunt charted the commercial strategy at Revance Therapeutics and helped raise over $250 million in the 2014 IPO and follow-on financing.